More than 22 million people live in parts of Africa where conditions exist for the Ebola virus to jump from animals to humans, a bigger area than previously thought, researchers said Monday.
Sep 8, 2014
0
0
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
The World Health Organization said on Monday it was thrashing out a new list of priority pathogens that risk sparking pandemics or outbreaks and should be kept under close observation.
Nov 21, 2022
0
5
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. ...
Jan 17, 2019
0
42
For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes ...
Aug 26, 2015
0
74
Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and nonhuman primates with ...
Jul 19, 2022
0
117
A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...
Jun 19, 2017
0
105
Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published online today in the journal ...
Apr 29, 2016
0
51
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...
Jul 17, 2018
0
13
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...
Nov 13, 2018
0
58
